419622-Awarded - Poland – Pharmaceutical products – Successive supply of medicinal and complementary products (cyclosporine, methotrexate, tacrolimus, folic acid, mometasone, emollients) for the implementation of a non-commercial clinical trial "Prospective, randomized, open-label phase III clinical trial with blinded endpoint assessment assessing the efficacy and safety of cyclosporine and methotrexate in children and adolescents with atopic dermatitis".

This tender with title 419622-Awarded - Poland – Pharmaceutical products – Successive supply of medicinal and complementary products (cyclosporine, methotrexate, tacrolimus, folic acid, mometasone, emollients) for the implementation of a non-commercial clinical trial "Prospective, randomized, open-label phase III clinical trial with blinded endpoint assessment assessing the efficacy and safety of cyclosporine and methotrexate in children and adolescents with atopic dermatitis". -- Contract Value: 642 235,00 PLN has been published on Bidding Source portal dated 03 Jul 2025 for the country of Poland. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.